Active Ingredient: CABAZITAXEL
Proprietary Name: CABAZITAXEL
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 60MG/1.5ML (40MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207619
Product Number: 001
Approval Date: Jun 23, 2022
Applicant Holder Full Name: BRECKENRIDGE PHARMACEUTICAL INC
Marketing Status:
Discontinued
Patent and Exclusivity Information